Dr. Thistlethwaite is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 619-543-7777Fax+1 619-543-2652
Education & Training
- UPMC Medical EducationFellowship, Thoracic Surgery, 1994 - 1997
- Massachusetts General HospitalResidency, Surgery, 1989 - 1994
- Harvard Medical SchoolClass of 1989
Certifications & Licensure
- CA State Medical License 1997 - 2025
- PA State Medical License 1994 - 1998
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2007-2014
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Join now to see all
Publications & Presentations
PubMed
- 1458 citationsManagement of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension A Scientific Statement Fro...Michael R. Jaff, M. Sean McMurtry, Stephen L. Archer, Mary Cushman, Neil A. Goldenberg
Circulation. 2011-04-26 - 218 citationsOperative classification of thromboembolic disease determines outcome after pulmonary endarterectomyPatricia A. Thistlethwaite, Makato Mo, Michael M. Madani, Reena Deutsch, Daniel G. Blanchard
The Journal of Thoracic and Cardiovascular Surgery. 2002-12-01 - 64 citationsMDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension.Hui Shen, Jiao Zhang, Chen Wang, Pritesh P. Jain, Mingmei Xiong
Circulation. 2020-09-22
Press Mentions
- Preventing Pulmonary Arterial Hypertension – an Incurable DiseaseMay 18th, 2022
- Prevention of Pulmonary Arterial Hypertension-Incurable DiseaseMay 18th, 2022
- Targeting Molecular Pathway That Causes Pulmonary Arterial HypertensionMay 6th, 2022
Grant Support
- Molecular Mechanisms Of Pulmonary HypertensionNational Heart, Lung, And Blood Institute2002–2011
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: